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Small RNA (sRNA)-mediated RNA interference (RNAi) is a conserved regulatory mechanism
for gene expression throughout the domain Eukarya. Recent studies have shown that sRNAs
can move between a host and an interacting organism to induce gene silencing in trans, a
mechanism termed “Cross-Species RNAi” or, in many cases, “Cross-Kingdom RNAi.” Patho-
gens and parasites transport sRNAs into host cells during infection and silence host defense
genes to suppress immunity, whereas hosts can also deliver their sRNAs into interacting
microbes or parasites to suppress infection. Recent studies of different plant and animal hosts
and their interacting organisms have unveiled extracellular vesicles (EVs) as vehicles of sRNA
exchange in cross-species and cross-kingdom RNAi. The discovery of the pivotal role of
sRNAs and EVs in cross-species and cross-kingdom communication offers innovative tools
for pathogen and pest control in agriculture and biomedicine.
Cross-kingdom RNAi
sRNAs—including microRNAs (miRNAs) that are processed by Dicer-like (DCL) proteins
from single-stranded stem-loop–forming RNA precursors and small interfering RNAs (siR-
NAs) that are processed by DCL proteins from double-stranded RNA (dsRNA) precursors—
are loaded into Argonaute (AGO) proteins to induce silencing of genes with complementary
sequences [1]. Some sRNAs from diverse classes of pathogens and parasites are transported
into host cells and induce cross-kingdom or cross-species RNA silencing to facilitate infection
(Fig 1). Fungal pathogens, including ascomycete and basidiomycete species, can deliver
sRNAs into their respective hosts [2–6]. In detail, Botrytis cinerea, the grey mold fungal patho-
gen that infects over 1,000 plant species, delivers sRNAs into plant cells and hijacks host RNAi
machinery by loading its sRNAs into the Arabidopsis AGO1 protein to trigger silencing of host
immunity genes, including mitogen-activated protein kinases (MAPKs), cell-wall–associated
kinases, and other defense and signaling proteins [2]. A panel of sRNAs from Verticillium dah-
liae, which causes Verticillium wilt in many plant hosts, also move into plant cells and associate
with the host AGO1 protein to silence host genes involved in plant defense [4]. A genome-
wide association study shows that the white mold fungal pathogen Sclerotinia sclerotiorum
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produces sRNAs that, to facilitate infection, can target plant genes associated with quantitative
disease resistance [5]. A miRNA-like sRNA from Puccinia striiformis, the causal agent of the
destructive wheat stripe rust, targets wheat pathogenesis-related genes and suppresses host
immunity to achieve successful infection [3]. Likewise, the parasitic plant Cuscuta campestris
(dodder) transports several miRNAs into A. thaliana and Nicotiana benthamiana to promote
invasion [7].
Cross-kingdom sRNA trafficking from a fungal pathogen to an animal host was also
observed recently. Beauveria bassiana, an insect fungal pathogen, exports a miRNA-like RNA
(bba-milR1) to the host mosquito, which induces cross-kingdom RNAi to suppress host
immunity [6]. Strikingly, this insect fungal pathogen-derived bba-milR1 also binds to host
AGO1 and silences mosquito target gene Toll receptor ligand Spätzle 4 [6], which is consistent
with the mechanism used by transported sRNAs from plant fungal pathogens [2, 4].
In addition to eukaryotic pathogens, prokaryotic microbes can also use cross-kingdom
RNA trafficking to manipulate gene expression in the hosts. Specifically, the root-nodule bac-
terium Rhizobium delivers tRNA-derived sRNA fragments (tRFs) into soybeans to suppress
host genes involved in nodule formation and root development, which enhances nodulation
efficiency [8]. Surprisingly, these Rhizobium tRFs also function through host AGO1 [8], just
like fungal pathogen-derived sRNAs that are bound with host AGO1 to silence host target
genes [2, 4, 6]. Furthermore, it has long been known that virus- or viroid-derived sRNAs can
target various host protein-coding genes to facilitate infection in both plant and animal hosts
[9–14]. A recent study revealed that the targeting of a long noncoding RNA in tomato by
tomato yellow leaf curl virus-derived sRNAs contributes to disease symptoms [15].
Cross-kingdom RNAi is bidirectional. Plant hosts also transport sRNAs into fungal patho-
gens to suppress the expression of virulence-related genes, which contributes to plant defense
Fig 1. Cross-species and cross-kingdom RNAi between host and coinhabitants. (A) Cross-species RNAi between mammals and parasites.
Parasites produce EVs containing parasitic sRNAs, which are internalized by mammalian cells to silence host genes involved in inflammation
and innate immunity. Animal cells can deliver sRNAs into interacting organisms. They also secrete EVs (e.g., exosomes or MVs) containing
host sRNAs. It is likely that animal hosts may also transport sRNAs using EVs into parasites to suppress parasitic genes. (B) Cross-kingdom
RNAi between plants and fungal pathogens. Fungal sRNAs translocate into plant cells and hijack host AGO protein of the RNAi machinery to
suppress plant immune responses. It is still unclear how pathogens transport sRNAs. Conversely, plants secrete EVs to transport host sRNAs
into pathogens to silence fungal genes involved in virulence. The “?” indicates a prediction that has not been validated experimentally. AGO,
Argonaute; EE, early endosome; ER, endoplasmic reticulum; EV, extracellular vesicle; MV, microvesicle; MVB, multivesicular body; RNAi,
RNA interference; sRNA, small RNA; TGN, trans-Golgi network.
https://doi.org/10.1371/journal.ppat.1008090.g001
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responses. Translocation of plant endogenous sRNAs into fungi was clearly demonstrated by
sRNA profiling of fungal cells purified from infected plant tissue [16]. Cai and colleagues
developed an innovative sequential protoplastation method, which allowed for the removal of
all plant cells and the purification of B. cinerea protoplasts/cells from infected Arabidopsis tis-
sue [17]. These purified fungal cells contain host miRNAs and siRNAs, including Trans-acting
siRNAs, also called secondary phasing siRNAs (phasiRNAs) [16]. These Arabidopsis sRNAs
are delivered into interacting B. cinerea cells to induce silencing of fungal genes that are
involved in pathogenicity, many of which are related to vesicle trafficking [16]. Mutated B.
cinerea strains with a deletion in these target genes displayed reduced pathogenicity on plant
hosts [16]. Another study found that cotton miRNA166 and miRNA159 accumulated in the
mycelium of V. dahliae grown on artificial agar medium 30 days post re-isolation from
infected tissue, which suggests that cotton miRNAs can translocate into V. dahliae [18]. Both
cotton miRNAs trigger silencing of V. dahliae genes involved in virulence, Ca2+-dependent cys-
teine protease (Clp-1), and isotrichodermin C-15 hydroxylase (HiC-15), which enhances disease
resistance against this vascular pathogen [18]. Similarly, the wheat miRNA1023 suppresses an
alpha/beta hydrolase gene in Fusarium graminearum, which is important for fungal infection
[19]. Plant sRNA-induced silencing of pathogen genes is not restricted to fungi. A similar phe-
nomenon was later observed in the interaction between plants and an oomycete pathogen,
Phytophthora capsici. Arabidopsis may use secondary sRNAs to silence Phytophthora genes
during infection [20].
Cross-species RNAi also exists in animal–parasite interactions. Some mammalian parasites
use cross-species RNAi strategies to silence host genes and enable infection. For instance, the
gastrointestinal nematode Heligmosomoides polygyrus (also known as H. bakeri) secretes
sRNAs, including miRNAs, which suppress type II innate immune response in the murine
host [21]. Conversely, some animal hosts also deliver sRNAs into parasites. Patients who suffer
from sickle cell anemia show abnormal erythrocyte development but exhibit resistance to the
malaria parasite Plasmodium falciparum. One of the reasons for malaria resistance is that these
patients accumulate higher levels of a specific panel of miRNAs, which are transported into the
parasite and suppress P. falciparum virulence [22]. Though P. falciparum lacks canonical
RNAi components, such as DCLs and AGOs, the authors demonstrated that cross-kingdom
RNA regulation occurs through impaired ribosomal loading by the fusion of host miRNAs
with the parasite target mRNAs. This chimerization blocks target mRNA translation and
causes an inhibition of parasite growth [22]. Anti-Plasmodium cross-kingdom RNA regulation
was also reported based on the human miR-451/140 targeting the P. falciparum antigen eryth-
rocyte membrane protein-1 (PfEMP1). Human miR451 was found in the parasitic cell in com-
plex with human AGO2, providing the first example of cross-kingdom delivery of an sRNA–
AGO complex [23].
In the mammalian gut, miRNAs secreted by human and mouse intestinal epithelial cells
were shown to influence gene expression even in gut bacteria that lack canonical RNAi
machinery, suggesting a regulatory role of host miRNAs in gut microbiome homeostasis [24].
Furthermore, dietary plant miRNAs can also enter gut bacteria through plant-derived exo-
some-like nanoparticles, further shaping the gut microbial community [25]. RNAi does not
exist in prokaryotes per se; however, bacteria have various ribonucleases, including type III
ribonucleases [26], which may interact with the host or dietary miRNAs to interfere with bac-
terial mRNA expression. The increasing number of discovered cases of cross-species and
cross-kingdom RNAi or RNA Trans-regulation across diverse host–microbe and host–parasite
systems has made it clear that cross-species and cross-kingdom RNA communication is likely
a ubiquitous mechanism in host–microbe and host–parasite interactions.
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008090 December 30, 2019 3 / 13
EVs in animal–parasite interactions
In mammals, RNAs circulating through body fluids are often encapsulated in extracellular ves-
icles (EVs). EVs are membrane-surrounded vesicular compartments released by cells to the
extracellular environment to transport proteins, RNAs, lipids, and other molecules to other
cells or to interacting organisms [27]. EVs are categorized into multiple classes based on their
biogenesis pathways and associated protein markers. In mammalian systems, multiple classes
of EVs have been shown to carry sRNAs. In particular, exosomes, which are derived from mul-
tivesicular bodies (MVBs) and have tetraspanin proteins as one of the key protein markers
[28], play an important role in sRNA trafficking [29]. Microvesicles, which bud from the
plasma membrane, can also transport sRNAs into recipient cells [30]. Both types of EVs are
involved in cell-to-cell communication in homeostasis, immune signaling, and neural net-
works [31, 32]. While exosomes and microvesicles are secreted during normal cellular pro-
cesses, apoptotic bodies are formed during programmed cell death [33]. Functional molecules,
including RNAs, can be detected in apoptotic bodies [34, 35]. Some reports have shown that
apoptotic bodies can transport these functional molecules into recipient cells [35, 36], though
whether they are also involved in cross-kingdom communication between parasites/microbes
and animal hosts remains to be explored.
It is not surprising that pathogens and pests would evolve to exploit or target these natural
cell-to-cell communication pathways. Diverse parasites have been shown to use EVs to deliver
sRNAs to host cells and modulate host gene expression (Fig 1A) [37]. The miRNA-containing
EVs that are released by the gastrointestinal nematode—or helminth—H. polygyrus are inter-
nalized by host mouse cells and suppress inflammation and innate immune responses during
infection [21]. Many of the nematode miRNAs share common ancestry and identical seed sites
with miRNAs of the mouse host, such that they would be expected to be able to tap into exist-
ing miRNA target networks in the mouse cell. However, the RNAi mechanisms used between
these two animals are complex, as the nematode packages a nematode-specific AGO protein
(extra cellular worm Argonautes [exWAGO]) into the EVs bound to siRNAs from rapidly
evolving nongenic regions of the parasite genome [38]. Indeed, these studies suggest that dif-
ferent parasites and pathogens might have diverse tools for RNA-mediated suppression of host
genes. The study of these pathogen RNA transmission mechanisms may guide new strategies
for effective therapeutic delivery of RNAs (for example, delivering RNA–AGO complexes,
rather than RNA alone) [39]. Since the EVs from helminths are immune suppressive, the EVs
and their RNA cargoes also represent another potential therapy for treating colitis and allergies
in humans [21, 40, 41].
In mammalian systems, EVs have been shown to transport sRNAs between cells within the
organism; we speculate that EVs may also be used by the host cells to deliver sRNAs to its
interacting organisms, such as parasites and pathogens.
EVs in plant–microbe interactions
In 1967, plant EVs were initially observed in carrots by electron microscopy [42]. Forty years
later, Regente and colleagues isolated plant EVs from extracellular wash fluids of imbibed
sunflower seeds [43]. However, the origin of plant EVs still remained unknown. In mammals,
exosomes are a class of EVs derived from MVBs. Mammalian tetraspanins cluster of differenti-
ation (CD)63, CD81, and CD9 are enriched in exosome membranes and are commonly used
as biomarkers to isolate and phenotype exosomes [28]. Arabidopsis encodes 17 members of the
TETRASPANIN (TET) family [44], and two Arabidopsis TETs (TET8 and TET9) are induced
upon infection by B. cinerea. Moreover, TET8-associated vesicles accumulated to a high level
at the fungal infection sites [16]. TET8 is colocalized with Arabidopsis MVB-marker Rab5-like
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GTPase ARA6 inside the cell, and TET8-associated vesicles are secreted into the apoplast [16],
suggesting that TET8-associated EVs are derived from MVBs and secreted into apoplastic
space and can, therefore, be considered bona fide plant exosomes. These exosomes contain
plant-endogenous sRNAs and are efficiently taken up by B. cinerea fungal cells. Plant exo-
somes deliver sRNAs into fungal pathogens to suppress fungal infection by inducing silencing
of fungal virulence-related genes. Similarly, Arabidopsis also transports secondary phasiRNAs
from PPR gene clusters into an oomycete pathogen, P. capsici, likely also by EVs, which silence
target genes in the pathogen [20]. Thus, plants have adapted EV-mediated cross-kingdom
RNAi for immune responses during the coevolutionary arms race with interacting pathogens
(Fig 1B).
In addition to exosomes, PENETRATION (PEN)1-associated EVs, which contain several
stress-response–related proteins, were identified in Arabidopsis [45]. The biogenesis pathway
of PEN1-associated EVs remains unclear, although PEN1 was originally identified as a
plasma-membrane–associated plant-specific syntaxin [46]. PEN1-associated EVs were purified
from the apoplast wash fluid of Arabidopsis leaves using an ultracentrifugation speed (40,000g)
[45, 47], which is slower than that used to isolate TET-associated exosomes (100,000g) [16].
Secretion of PEN1-assoiated EVs was increased during infection by a bacterial pathogen (Pseu-
domonas syringae) or following treatment with the phytohormone salicylic acid [45]. Baldrich
and colleagues analyzed the sRNA population in these EVs isolated from uninfected Arabidop-
sis leaves and found that these EVs carry predominantly “tiny RNAs,” which are 10–17 nucleo-
tides in length and derived mainly from the positive strand of mRNA transcripts [48]. It is not
clear whether these tiny RNAs have any biological function. Since pathogen-infected samples
were not included in this study, whether this class of EVs is also involved in plant and patho-
gen interactions and whether tiny RNAs are delivered into pathogen cells via these EVs remain
unclear. PEN1 and the ATP-binding cassette (ABC)-transporter PEN3 are incorporated into
extracellular encasements surrounding the haustoria of the powdery mildew fungus, Golovino-
myces orontii, suggesting that PEN1-asociated EVs contribute to defense responses against
powdery mildew [45, 49, 50]. A third type of plant EV, which is derived from a novel double-
membrane–bound exocyst-positive organelle (EXPO) [51], has been reported in plants. These
EXPO-derived EVs were discovered through transient expression of exocyst subunit exo70
family protein E2 (Exo70E2), a component of exocyst complex, in protoplasts from Arabidop-
sis suspension-cultured cells. Whether EXPO-derived EVs contain RNAs and are involved in
cross-kingdom communication remains to be discovered.
Similar to animal EVs, which comprise diverse, heterogeneous, and cell-type–specific popu-
lations with a wide range of biological functions in cell-to-cell communication [52], the previ-
ously cited studies suggest that plant cells also secrete different classes of EVs that may contain
specific cargoes. Establishing plant EV biomarkers (such as TET8, PEN1, and Exo70E2) will
enable immuno-based analysis of EVs to further understand the biological functions of EVs in
complex biological systems such as plant–microbe interactions.
Though EV-mediated transport is a key mechanism for RNA secretion and delivery
between hosts and microbes/pests, nonvesicular extracellular RNAs have also been discovered.
Specifically, in human plasma, extracellular RNAs were found within RNA–protein com-
plexes, including AGO proteins and high-density lipoprotein complexes [53–56]. Additionally,
exomeres, extracellular nonmembranous nanoparticles, have recently been discovered in
mammalian systems containing AGO1, AGO2, and AGO3 proteins; amyloid precursor pro-
teins; RNAs; and DNAs. Notably, these exomeres contained a profile of macromolecules dis-
tinct from exosomes [57, 58]. In a plant system, Baldrich and colleagues found that sRNAs
were still present in apoplastic wash fluid, which they believe was depleted of EVs by centrifu-
gation at 40,000g [48]. However, small, RNA-containing EVs, such as exosomes, are mostly
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008090 December 30, 2019 5 / 13
collected at higher speeds (between 100,000g and 120,000g) from various plant and mamma-
lian systems [52, 59–61], as well as from fungi [62, 63]. Furthermore, plant tetraspanin-labeled
exosomes, which transport sRNAs from the hosts to fungal cells, were much more enriched
after centrifugation at a speed of 100,000g than at 40,000g [16]. Therefore, it is unlikely that
plant EVs can be depleted at 40,000g, and, consequently, whether nonvesicular RNAs are
secreted by plants requires further investigation. Furthermore, the origins of nonvesicular
RNAs and their potential role in cross-kingdom RNAi remain to be explored.
RNA and EV-based innovative tools for disease control
Global disease control mainly relies on chemical protection measures using fungicides, pesti-
cides, and antibiotics, which not only threatens the health of humans and ecosystems but also
generates novel uncontrollable drug-resistant pathogenic strains [64]. We are in urgent need
of innovative, durable, and eco-friendly fungicides and antimicrobial drugs to avoid a global
collapse in our ability to control pathogen/parasite infections in both plants and animals,
including humans.
One direct application of cross-kingdom RNAi is host-induced gene silencing (HIGS), a
promising technology in which transgenic plants express dsRNAs or sRNAs that target patho-
gen or insect virulence-related genes to combat plant diseases [65, 66]. This approach has also
made it possible to control multiple pathogens spontaneously by designing dsRNA and sRNA
constructs that target multiple genes from different pathogens [4]. Although HIGS is effective,
it involves the generation of genetically modified organisms (GMOs), which is not only techni-
cally challenging in many crop species but unfortunately still a concern for many consumers.
Furthermore, GMOs are banned in European agricultural productions, rendering HIGS not
practically usable, at least in the near future.
Environmental RNAi, initially discovered in the nematode Caenorhabditis elegans [67], is
the cellular uptake of RNAs from the environment and the induction and spreading of sys-
temic gene silencing. Forward genetics screening in C. elegans revealed that Systemic RNA
interference deficient (SID)-1 and SID-2 encode for two dsRNA transmembrane channel pro-
teins, which are required for dsRNA uptake and systemic gene silencing [68, 69]. In this inver-
tebrate system, there is higher uptake and silencing efficiency for long dsRNA (>60 bp) than
short (<25 bp) or single-stranded RNA [70, 71]. Inspired by environmental RNAi of C. ele-
gans, Wang and colleagues tested whether fungal cells can also take up RNAs from the envi-
ronment and observed rapid RNA uptake by B. cinerea cells [4]. These RNAs induce silencing
of fungal genes in a sequence-specific manner. Unlike C. elegans, which primarily takes up
long dsRNAs, fungal uptake of environmental RNAs seems less dependent on RNA size,
because both short sRNA duplexes and long dsRNAs are taken up by fungi and induce robust
gene silencing in the fungal cells [4]. Fungal environmental RNAi allowed plant scientists to
design spray-induced gene silencing (SIGS) to control fungal and potentially other pathogens
through spray application of pathogen gene-targeting dsRNAs and sRNAs (Fig 2A) [4, 72, 73].
Wang and colleagues demonstrated that spray application of long dsRNAs or sRNA duplexes
that target B. cinerea DCL1 and DCL2 genes can effectively suppress grey mold diseases on
fruits, vegetables, and flowers [4]. Koch and colleagues have shown that SIGS can also effec-
tively control a fungal disease in the monocot barley [73]. Spray application of a long dsRNA
that targets fungal cytochrome P450 lanosterol C-14α-demethylase genes on barley leaves can
inhibit F. graminearum infection [73]. Similarly, application of exogenous dsRNAs helps pro-
tect Brassica napus from infection by S. sclerotiorum and B. cinerea [74]. These pathogen gene-
targeting dsRNAs and sRNAs represent a novel class of eco-friendly fungicides, “RNA fungi-
cides” (Fig 2A).
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Exogenous RNAs can either be directly internalized into fungal cells [4] or indirectly via
passage through plant tissue before transport into interacting pathogen cells [75]. Further-
more, Koch and colleagues observed inhibition of F. graminearum growth in the distal
nonsprayed barley leaf tissue [73], suggesting that sprayed dsRNAs taken up by plant cells
moved through vasculature systemically. While the molecular mechanism of RNA uptake in
C. elegans and some nematodes is based on SID proteins, which are not present in plants or
fungi, the mechanisms for uptake of environmental RNAs into fungi and plants need further
investigation.
Obviously, the effectiveness of SIGS relies on extracellular RNA stability and RNA uptake
efficiency of pathogens. To technically improve RNA stability, Mitter and colleagues docked
an antiviral dsRNA onto double hydroxide clay nanosheets, which increased the efficacy of
plant antiviral protection [75]. In addition, the use of artificial vesicles or liposomes to protect
RNAs could be an effective strategy to improve SIGS for plant protection and to develop
potential antifungal drugs for therapy, as some fungi are capable of taking up EVs efficiently
(Fig 2) [16, 76]. Since EV trafficking is also a natural RNA transport mechanism in mammals,
it is exciting to consider the potential for extension of artificial vesicle-protected RNA-based
antifungal strategies in humans (Fig 2B). Indeed, lipid-based nanoparticles have been used to
stabilize therapeutic compounds, including sRNAs, in biomedical applications [77]. For exam-
ple, liposomal amphotericin B, the world’s leading antifungal drug, was based on liposomal
formulation of amphotericin B to reduce toxicity [78]. Moreover, Walker and colleagues have
observed that amphotericin B–containing liposomes remained intact during transit through
the cell walls of phylogenetically distant fungal pathogens, Candida albicans and Cryptococcus
neoformans, although liposomes (60–80 nm) are larger than the theoretical cell wall porosity
Fig 2. SIGS is an efficient disease control strategy in plants and potentially in humans. (A) Spray application of
dsRNAs and sRNAs that target pathogen/pest genes can potentially control plant diseases. The SIGS-based protection
can be prolonged by incorporating RNAs into artificial vesicles (black circle) or nanoparticles (pink rhombus) to
protect RNAs from degradation or water rinsing. (B) Future RNA-based antifungal drugs have the potential to control
human mycoses. Artificial vesicles/liposomes will likely facilitate the RNA delivery. Figures were created with
BioRender. The “?” indicates a prediction that has not yet been validated experimentally. dsRNA, double-stranded
RNA; SIGS, spray-induced gene silencing; sRNA, small RNA.
https://doi.org/10.1371/journal.ppat.1008090.g002
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(approximately 5.8 nm)[79]. This work suggests that the fungal cell wall is deformable and vis-
coelastic to allow liposomes to pass, which makes it possible to efficiently deliver new genera-
tion of antifungal drugs, including RNA-based drugs, using liposomes/artificial vesicles [79].
In 2018, the Food and Drug Administration (FDA) approved the very first therapeutic siRNA
drug, patisiran, to treat hereditary transthyretin-mediated amyloidosis, a rare, debilitating and
often fatal genetic disease [80]. Patisiran uses a lipid nanoparticle delivery mechanism to trans-
fer 21-bp siRNA duplex into cells in the liver [80]. Besides patisiran, there are at least 6 other
RNAi therapeutics already in phase III clinical trials [80].
Although more than 300 human or animal pathogenic fungal species have been recorded
and fungal infections display disproportional high mortality rates, mycoses are rather
neglected in infection biology research [81]. Survival rates of patients suffering from respira-
tory and systemic fungal infections often caused by the opportunistic fungi Candida (candidia-
sis), Aspergillus (aspergillosis), or Cryptococcus (cryptococcosis) are low due to limited
availability of antifungal drugs. Drug-resistant fungal strains have already emerged to all the
commonly used antifungal drugs [64]. Therefore, innovative drugs to combat fungal infections
are urgently needed, and based on the effects observed for antifungal SIGS approaches in
plants, development of novel antifungal RNA therapeutics and artificial vesicle/liposome-
mediated delivery methods may be effective in the fight against mycoses.
Future perspectives
The field of cross-species and cross-kingdom communication via RNA is still in its infancy,
yet an increasing number of studies across diverse systems demonstrate that mobile RNAs are
key regulatory molecules that shape the interactions between hosts and interacting pathogens
or organisms. Plants and animals deliver sRNAs into interacting (micro-)organisms to inhibit
infection, and pathogens and parasites can, in turn, transport sRNAs into the host to suppress
host immunity. Current studies show that EVs play an essential role in transporting sRNAs
from the plant hosts to pathogens and from parasitic nematodes to mammalian hosts, and it is
very likely that mammalian hosts could also utilize EVs to deliver sRNAs into their parasites
and pathogens, though this is currently just speculation. Recent advances in methodology
development for isolating different classes of EVs in mammalian systems provide excellent
tools and guidelines to study RNA delivery in cross-species and cross-kingdom RNAi [82, 83].
Although there is diversity in the properties of EVs based on their cell and tissue origin (and
purification techniques, which can also impact the exact profile of RNAs and proteins found
in EVs), it is clear that small EVs, including exosomes, play an important role in delivering
sRNAs [60, 84, 85].
The discovery of cross-species and cross-kingdom RNAi and fungal RNA uptake has
inspired scientists to design novel disease control strategies against pathogens and pests in
agriculture, such as HIGS and SIGS. Structural and mechanistic studies of EVs in sRNA traf-
ficking allows for the development of innovative delivery methods of sRNAs using artificial
vesicles, or nanoparticles, which may also be considered for therapeutic applications in mam-
malian systems. We speculate that future development and application of a new generation of
RNA-based fungicides and antifungal drugs will be an important research direction to control
diseases caused by eukaryotic pathogens and parasites.
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